1. Home
  2. BAK vs KMDA Comparison

BAK vs KMDA Comparison

Compare BAK & KMDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Braskem SA ADR

BAK

Braskem SA ADR

N/A

Current Price

$0.75

Market Cap

434.3M

Sector

Industrials

ML Signal

N/A

Logo Kamada Ltd.

KMDA

Kamada Ltd.

N/A

Current Price

$7.76

Market Cap

460.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BAK
KMDA
Founded
1972
1990
Country
Brazil
Israel
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
434.3M
460.3M
IPO Year
2002
2013

Fundamental Metrics

Financial Performance
Metric
BAK
KMDA
Price
$0.75
$7.76
Analyst Decision
Sell
Strong Buy
Analyst Count
6
3
Target Price
$1.33
★ $13.75
AVG Volume (30 Days)
★ 3.1M
110.2K
Earning Date
11-12-2026
11-09-2026
Dividend Yield
N/A
★ 7.15%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$7.86
$12.75
Revenue Next Year
$5.37
$13.63
P/E Ratio
★ N/A
$24.59
Revenue Growth
N/A
N/A
52 Week Low
$0.74
$6.63
52 Week High
$5.40
$9.35

Technical Indicators

Market Signals
Indicator
BAK
KMDA
Relative Strength Index (RSI) 24.96 47.71
Support Level $0.74 $6.91
Resistance Level $1.20 $8.16
Average True Range (ATR) 0.11 0.25
MACD -0.02 0.04
Stochastic Oscillator 1.56 63.92

Price Performance

Historical Comparison
BAK
KMDA

About BAK Braskem SA ADR

Braskem SA is engaged in the manufacture, sale, import and export of chemicals, petrochemicals and fuels, as well as the production, supply and sale of utilities such as steam, water, compressed air and industrial gases. It also provides industrial services and is engaged in the production, supply and sale of electric energy and gas for its own use and use by other companies. Its segments include Brazil, USA and Europe; and Mexico. The Brazil segments delivered the majority of the revenue from the production and sale of chemicals; the supply of electricity and other inputs produced in these complexes to second-generation producers located in the petrochemical complexes; and the production and sale of PE, including the production of green PE made from renewable resources, and of PP.

About KMDA Kamada Ltd.

Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.

Share on Social Networks: